cornellleukemia.com
Dr. Gail Roboz to Lead Clinical Trial in AML for Novel Immunotherapy, UCART123
In the summer of 2015, Weill Cornell Medical College and Cellectis, a French pharmaceutical company, announced a translational research collaboration for a new allogeneic chimeric antigen receptor …